Bank of Montreal’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-87,005
| Closed | -$1.57M | – | 3380 |
|
|
2021
Q3 | $1.57M | Sell |
87,005
-4,475
| -5% | -$80.8K | ﹤0.01% | 2053 |
|
|
2021
Q2 | $1.57M | Buy |
91,480
+26,098
| +40% | +$449K | ﹤0.01% | 2086 |
|
|
2021
Q1 | $1.9M | Sell |
65,382
-73,847
| -53% | -$2.15M | ﹤0.01% | 1577 |
|
|
2020
Q4 | $880K | Buy |
+139,229
| New | +$880K | ﹤0.01% | 1966 |
|
|
2020
Q1 | – | Sell |
-5,491
| Closed | -$10K | – | 3728 |
|
|
2019
Q4 | $10K | Buy |
5,491
+2,335
| +74% | +$4.25K | ﹤0.01% | 4022 |
|
|
2019
Q3 | $3K | Buy |
3,156
+74
| +2% | +$70 | ﹤0.01% | 4097 |
|
|
2019
Q2 | $7K | Buy |
3,082
+2,328
| +309% | +$5.29K | ﹤0.01% | 4133 |
|
|
2019
Q1 | $4K | Sell |
754
-207
| -22% | -$1.1K | ﹤0.01% | 3636 |
|
|
2018
Q4 | $7K | Buy |
961
+481
| +100% | +$3.5K | ﹤0.01% | 3606 |
|
|
2018
Q3 | $7K | Sell |
480
-7,464
| -94% | -$109K | ﹤0.01% | 3694 |
|
|
2018
Q2 | $159K | Buy |
7,944
+152
| +2% | +$3.04K | ﹤0.01% | 2588 |
|
|
2018
Q1 | $137K | Buy |
7,792
+7,415
| +1,967% | +$130K | ﹤0.01% | 2589 |
|
|
2017
Q4 | $9K | Hold |
377
| – | – | ﹤0.01% | 3468 |
|
|
2017
Q3 | $10K | Sell |
377
-6,760
| -95% | -$179K | ﹤0.01% | 3397 |
|
|
2017
Q2 | $194K | Buy |
7,137
+6,760
| +1,793% | +$184K | ﹤0.01% | 2420 |
|
|
2017
Q1 | $11K | Hold |
377
| – | – | ﹤0.01% | 3247 |
|
|
2016
Q4 | $11K | Buy |
+377
| New | +$11K | ﹤0.01% | 3248 |
|